Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression

Open access

Abstract

Objective: CT quantification of aortic valve calcification (CT-AVC) is useful in the assessment of aortic stenosis severity. Our objective was to assess its ability to track aortic stenosis progression compared with echocardiography. Methods: Subjects were recruited in two cohorts: (1) a reproducibility cohort where patients underwent repeat CT-AVC or echocardiography within 4 weeks and (2) a disease progression cohort where patients underwent annual CT-AVC and/or echocardiography. Cohen’s d-statistic ( d ) was computed from the ratio of annualised progression and measurement repeatability and used to estimate group sizes required to detect annualised changes in CT-AVC and echocardiography. Results: A total of 33 (age 71±8) and 81 participants (age 72±8) were recruited to the reproducibility and progression cohorts, respectively. Ten CT scans (16%) were excluded from the progression cohort due to non-diagnostic image quality. Scan-rescan reproducibility was excellent for CT-AVC (limits of agreement −12% to 10 %, intraclass correlation (ICC) 0.99), peak velocity (−7% to +17%; ICC 0.92) mean gradient (−25% to 27%, ICC 0.96) and dimensionless index (−11% to +15%; ICC 0.98). Repeat measurements of aortic valve area (AVA) were less reliable (−44% to +28%, ICC 0.85). CT-AVC progressed by 152 (65–375) AU/year. For echocardiography, the median annual change in peak velocity was 0.1 (0.0–0.3) m/s/year, mean gradient 2 (0–4) mm Hg/year and AVA −0.1 (−0.2–0.0) cm 2 /year. Cohen’s d-statistic was more than double for CT-AVC ( d =3.12) than each echocardiographic measure (peak velocity d =0.71 ; mean gradient d =0.66; AVA d =0.59, dimensionless index d =1.41). Conclusion: CT-AVC is reproducible and demonstrates larger increases over time normalised to measurement repeatability compared with echocardiographic measures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/heartjnl-2020-317125

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Scan-rescan reproducibility of CT quantification of aortic valve calcification (CT-AVC) and echocardiographic assessment of aortic stenosis severity. Bland-Altman plots displaying the scan-rescan reproducibility of aortic stenosis severity measurements on serial CT-AVC (3.9±3.3 weeks) and echocardiography (1±0 days). VTI, velocity time integral.
Figure 1 Scan-rescan reproducibility of CT quantification of aortic valve calcification (CT-AVC) and echocardiographic assessment of aortic stenosis severity. Bland-Altman plots displaying the scan-rescan reproducibility of aortic stenosis severity measurements on serial CT-AVC (3.9±3.3 weeks) and echocardiography (1±0 days). VTI, velocity time integral.CC BY · PubMed Central
Figure 2 Aortic stenosis disease progression measured using CT quantification of aortic valve calcification (CT-AVC) and echocardiography. Annualised disease progression across each cohort using CT calcium scoring (A), peak aortic jet velocity (B), mean gradient (C) and aortic valve area (D). Relatively large annualised changes in the CT calcium score are observed compared with smaller changes and wide overlap in the measurements obtained by echocardiography. Dashed lines demonstrate the expected measurement repeatability from scan-rescan measurements.
Figure 2 Aortic stenosis disease progression measured using CT quantification of aortic valve calcification (CT-AVC) and echocardiography. Annualised disease progression across each cohort using CT calcium scoring (A), peak aortic jet velocity (B), mean gradient (C) and aortic valve area (D). Relatively large annualised changes in the CT calcium score are observed compared with smaller changes and wide overlap in the measurements obtained by echocardiography. Dashed lines demonstrate the expected measurement repeatability from scan-rescan measurements.CC BY · PubMed Central
Figure 3 CT calcium scoring and echocardiography to monitor disease progression in aortic stenosis. CT calcium scoring of the aortic valve (AV) and echocardiography in a patient at baseline (A–C) and 1 year (D–F). Baseline CT calcium scoring demonstrates CT quantification of aortic valve calcification (CT-AVC) of 2372 AU (A), transthoracic echocardiography of the AV shows calcified leaflets with a calcium score of 4 (B) and Doppler echocardiography demonstrates a peak velocity of 3.77 m/s (C) at baseline. At 1 year, CT-AVC has increased to 2773 (D), the AV calcium score on echocardiography is graded as 4 (E) and the peak jet velocity has increased to 3.95 m/s (F). AVA, aortic valve area; VTI, velocity time integral.
Figure 3 CT calcium scoring and echocardiography to monitor disease progression in aortic stenosis. CT calcium scoring of the aortic valve (AV) and echocardiography in a patient at baseline (A–C) and 1 year (D–F). Baseline CT calcium scoring demonstrates CT quantification of aortic valve calcification (CT-AVC) of 2372 AU (A), transthoracic echocardiography of the AV shows calcified leaflets with a calcium score of 4 (B) and Doppler echocardiography demonstrates a peak velocity of 3.77 m/s (C) at baseline. At 1 year, CT-AVC has increased to 2773 (D), the AV calcium score on echocardiography is graded as 4 (E) and the peak jet velocity has increased to 3.95 m/s (F). AVA, aortic valve area; VTI, velocity time integral.CC BY · PubMed Central
Figure 4 Sample sizes needed for studies of novel therapies in aortic stenosis using CT quantification of aortic valve calcification (CT-AVC) to assess their effect on disease progression. The number of participants required in a study to detect a given treatment effect size at different levels of power are plotted. For each modality an upper bound at 90% power and lower bound at 70% are plotted with α=0.05 for all. Nominal treatment effects up to 50% of the measured annualised progression for each modality are considered. Group size calculations should also consider the proportion of non-interpretable scans that may be encountered. AVA, aortic valve area.
Figure 4 Sample sizes needed for studies of novel therapies in aortic stenosis using CT quantification of aortic valve calcification (CT-AVC) to assess their effect on disease progression. The number of participants required in a study to detect a given treatment effect size at different levels of power are plotted. For each modality an upper bound at 90% power and lower bound at 70% are plotted with α=0.05 for all. Nominal treatment effects up to 50% of the measured annualised progression for each modality are considered. Group size calculations should also consider the proportion of non-interpretable scans that may be encountered. AVA, aortic valve area.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 1

  1. 10.1161/CIRCULATIONAHA.111.051052 · DOI · Paper page

Cited by

See all 48

Metadata

Authors
Doris, M. K., Jenkins, W., Robson, P., Pawade, T., Andrews, J. P., Bing, R., Cartlidge, T., Shah, A., Pickering, A., Williams, M. C., Fayad, Z. A., White, A., van Beek, E. J., Newby, D. E., & Dweck, M. R.
Affiliations
  • University of Edinburgh (GB)
  • Icahn School of Medicine at Mount Sinai (US)
  • The Queen's Medical Research Institute (GB)
  • The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, UK
Corresponding author
Dweck, Marc R
Venue
Heart
Publisher
BMJ
Published
2020-10-05
Volume
106
Issue
24
Pages
1906-1913
ISSN
  • 1355-6037 (ISSN-L)
  • 1468-201X
OpenAlex
W3091064912
Cited by
48
References
23
Citations by year
2026: 7 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 2
FWCI
3.56
Type
journal article
Language
en
Open access
Locations
  • Heart (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • British Heart Foundation (CH/09/002, FS/10/024, FS/10/026, FS/12/84/29814, FS/14/78, FS/14/78/31020, FS/17/79/33226, PG12/8/29371, SS/CH/09/002/2636)
  • National Institutes of Health (R01 HL071021)
  • The Wellcome Trust (WT103782AIA)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
Keywords
aortic stenosis, aortic valve calcification, disease progression, echocardiography, measurement reproducibility, aortic valve area, peak velocity, mean gradient, dimensionless index, sample size determination
MeSH terms
Aged, Aortic Valve, Aortic Valve Stenosis, Calcium, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, Echocardiography, Doppler, Reproducibility of Results, Multidetector Computed Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression. https://app.cochat.ai/papers/10.1136/heartjnl-2020-317125
The paper
Doris, M. K., Jenkins, W., Robson, P., Pawade, T., Andrews, J. P., Bing, R., Cartlidge, T., Shah, A., Pickering, A., Williams, M. C., Fayad, Z. A., White, A., van Beek, E. J., Newby, D. E., & Dweck, M. R. (2020). Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression. Heart. https://doi.org/10.1136/heartjnl-2020-317125

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.